These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7831996)

  • 41. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol.
    Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD
    J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
    Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
    Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo (123)I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients.
    Barnas C; Quiner S; Tauscher J; Hilger E; Willeit M; Küfferle B; Asenbaum S; Brücke T; Rao ML; Kasper S
    Psychopharmacology (Berl); 2001 Sep; 157(3):236-42. PubMed ID: 11605078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L; Lavalaye J; Linszen D; Dingemans PM; Booij J
    Am J Psychiatry; 2000 Jun; 157(6):1019-20. PubMed ID: 10831489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs.
    Farde L; Nordström AL
    Psychopharmacol Ser; 1993; 10():94-100. PubMed ID: 8103229
    [No Abstract]   [Full Text] [Related]  

  • 47. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
    Nordström AL; Farde L; Wiesel FA; Forslund K; Pauli S; Halldin C; Uppfeldt G
    Biol Psychiatry; 1993 Feb; 33(4):227-35. PubMed ID: 8097114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SPECT studies of D2 occupancy in low-dose haloperidol treatment.
    Hirschowitz J; Hitzemann R; Vallabhajosula S
    Am J Psychiatry; 1997 May; 154(5):715-6. PubMed ID: 9137141
    [No Abstract]   [Full Text] [Related]  

  • 49. Occupancy of striatal dopamine D2 receptors.
    Baron JC
    Psychiatry Res; 1995 Nov; 61(4):285-7. PubMed ID: 8748471
    [No Abstract]   [Full Text] [Related]  

  • 50. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.
    Moresco RM; Cavallaro R; Messa C; Bravi D; Gobbo C; Galli L; Lucignani G; Colombo C; Rizzo G; Velonà I; Smeraldi E; Fazio F
    J Psychopharmacol; 2004 Sep; 18(3):355-65. PubMed ID: 15358979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haloperidol serum concentrations and D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.
    Regenthal R; Künstler U; Junhold U; Preiss R
    Int Clin Psychopharmacol; 1997 Sep; 12(5):255-61. PubMed ID: 9466159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [D2-dopamine receptor upregulation and treatment response under neuroleptic therapy].
    Schröder J; Bubeck B; Sauer H
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S42-5. PubMed ID: 10907613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS; Mendhekar DN
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract]   [Full Text] [Related]  

  • 58. D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.
    Nyberg S; Farde L; Halldin C; Dahl ML; Bertilsson L
    Am J Psychiatry; 1995 Feb; 152(2):173-8. PubMed ID: 7840348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
    Nyberg S; Farde L; Halldin C
    Arch Gen Psychiatry; 1997 Oct; 54(10):953-8. PubMed ID: 9337776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.
    Farde L; Wiesel FA; Nordström AL; Sedvall G
    Psychopharmacology (Berl); 1989; 99 Suppl():S28-31. PubMed ID: 2573104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.